Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders
Vincerx Pharma (OTC Pink: VINC) has announced critical updates regarding its Special Meeting of Stockholders scheduled for July 16, 2025, focusing on the company's dissolution proposal. The company estimates potential distributions of $0.04 to $0.08 per share to stockholders following the approval of the dissolution plan.
The board unanimously recommends stockholders vote FOR the Dissolution Proposal, emphasizing that delays will result in continued operating costs and could reduce or eliminate funds available for distribution. U.S. stockholders may be eligible for capital loss tax benefits if they receive less than their tax basis in shares.
The Special Meeting will be held virtually at 10:00 a.m. Pacific time, with stockholders able to vote by phone through Advantage Proxy (1-877-870-8565) or online at www.proxyvote.com.
Vincerx Pharma (OTC Pink: VINC) ha comunicato aggiornamenti importanti riguardo alla sua Assemblea Straordinaria degli Azionisti prevista per il 16 luglio 2025, incentrata sulla proposta di scioglimento della società. L'azienda prevede una possibile distribuzione di 0,04-0,08 dollari per azione agli azionisti dopo l'approvazione del piano di scioglimento.
Il consiglio di amministrazione raccomanda all'unanimità agli azionisti di votare a FAVORE della Proposta di Scioglimento, sottolineando che eventuali ritardi comporterebbero costi operativi continui e potrebbero ridurre o azzerare i fondi disponibili per la distribuzione. Gli azionisti statunitensi potrebbero beneficiare di vantaggi fiscali per perdite in conto capitale qualora ricevessero meno del valore fiscale delle azioni possedute.
L'Assemblea Straordinaria si terrà in modalità virtuale alle ore 10:00, ora del Pacifico, e gli azionisti potranno votare telefonicamente tramite Advantage Proxy (1-877-870-8565) oppure online su www.proxyvote.com.
Vincerx Pharma (OTC Pink: VINC) ha anunciado actualizaciones importantes sobre su Junta Especial de Accionistas programada para el 16 de julio de 2025, centrada en la propuesta de disolución de la compañía. La empresa estima distribuciones potenciales de $0.04 a $0.08 por acción a los accionistas tras la aprobación del plan de disolución.
La junta directiva recomienda por unanimidad que los accionistas voten A FAVOR de la Propuesta de Disolución, enfatizando que retrasos implicarían costos operativos continuos y podrían reducir o eliminar los fondos disponibles para distribución. Los accionistas estadounidenses podrían ser elegibles para beneficios fiscales por pérdidas de capital si reciben menos que su base fiscal en acciones.
La Junta Especial se realizará de forma virtual a las 10:00 a.m., hora del Pacífico, y los accionistas podrán votar por teléfono a través de Advantage Proxy (1-877-870-8565) o en línea en www.proxyvote.com.
Vincerx Pharma (OTC Pink: VINC)는 2025년 7월 16일로 예정된 특별 주주총회에 관한 중요한 업데이트를 발표했습니다. 이번 회의는 회사 해산 제안에 초점을 맞추고 있습니다. 회사는 해산 계획 승인 후 주주들에게 주당 $0.04에서 $0.08의 배당금을 분배할 가능성이 있다고 예상합니다.
이사회는 만장일치로 주주들에게 해산 제안에 찬성 투표할 것을 권고하며, 지연 시 계속되는 운영 비용으로 인해 배분 가능한 자금이 줄어들거나 사라질 수 있음을 강조했습니다. 미국 주주들은 보유 주식의 세금 기준액보다 적은 금액을 받을 경우 자본 손실 세금 혜택을 받을 수 있습니다.
특별 주주총회는 태평양 표준시 기준 오전 10시에 온라인으로 개최되며, 주주들은 Advantage Proxy(1-877-870-8565)를 통해 전화로, 또는 www.proxyvote.com에서 온라인으로 투표할 수 있습니다.
Vincerx Pharma (OTC Pink : VINC) a annoncé des mises à jour importantes concernant son Assemblée Générale Extraordinaire des actionnaires prévue pour le 16 juillet 2025, axée sur la proposition de dissolution de la société. L'entreprise estime des distributions potentielles de 0,04 à 0,08 $ par action aux actionnaires après l'approbation du plan de dissolution.
Le conseil d'administration recommande à l'unanimité aux actionnaires de voter POUR la proposition de dissolution, soulignant que tout retard entraînerait des coûts d'exploitation continus et pourrait réduire ou éliminer les fonds disponibles pour distribution. Les actionnaires américains pourraient bénéficier d'avantages fiscaux en cas de perte en capital s'ils reçoivent moins que leur base fiscale sur les actions.
L'Assemblée Générale Extraordinaire se tiendra virtuellement à 10h00, heure du Pacifique, et les actionnaires pourront voter par téléphone via Advantage Proxy (1-877-870-8565) ou en ligne sur www.proxyvote.com.
Vincerx Pharma (OTC Pink: VINC) hat wichtige Neuigkeiten bezüglich seiner für den 16. Juli 2025 geplanten außerordentlichen Hauptversammlung der Aktionäre bekanntgegeben, die sich auf den Auflösungsantrag des Unternehmens konzentriert. Das Unternehmen schätzt potenzielle Ausschüttungen von 0,04 bis 0,08 US-Dollar pro Aktie an die Aktionäre nach der Genehmigung des Auflösungsplans.
Der Vorstand empfiehlt einstimmig, für den Auflösungsantrag zu stimmen, und betont, dass Verzögerungen zu fortlaufenden Betriebskosten führen und die verfügbaren Mittel für Ausschüttungen verringern oder eliminieren könnten. US-Aktionäre könnten Anspruch auf steuerliche Vorteile bei Kapitalverlusten haben, wenn sie weniger als ihre steuerliche Basis der Aktien erhalten.
Die außerordentliche Hauptversammlung findet virtuell um 10:00 Uhr pazifischer Zeit statt. Aktionäre können telefonisch über Advantage Proxy (1-877-870-8565) oder online unter www.proxyvote.com abstimmen.
- Potential distribution of $0.04 to $0.08 per share to stockholders upon dissolution approval
- Possible tax benefits for U.S. stockholders through capital loss recognition
- Board's unanimous recommendation provides clear direction for shareholders
- Continued delays in approval will reduce or eliminate funds available for distribution
- Company faces complete dissolution and delisting
- Risk of requiring bankruptcy court protection if dissolution is not approved
- Operating costs continue to deplete available funds while awaiting approval
Potential Distribution Range of
Failure to approve Dissolution Proposal will reduce or eliminate any potential distributions to stockholders
SAN MATEO, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced updated information regarding the Special Meeting of Stockholders of the Company (the “Special Meeting”) to consider the proposal to approve the dissolution and liquidation of the Company pursuant to the Plan of Liquidation and Dissolution (the “Dissolution Proposal”). The Special Meeting was adjourned to 10:00 a.m., Pacific time, on July 16, 2025 and will be held via live audio webcast at www.virtualshareholdermeeting.com/VINC2025SM2.
Vincerx currently estimates a range of between
Vincerx is urging ALL stockholders to vote IMMEDIATELY FOR the Dissolution Proposal.
Vincerx’s board of directors unanimously recommends that stockholders vote FOR the Dissolution Proposal and believes that approval of the Dissolution Proposal is extremely important to stockholders for a number of reasons, including the following:
- Preserve Possibility of Distributions. Vincerx currently estimates a range of between
$0.04 t o$0.08 per share of its outstanding common stock that could potentially be available for distribution. However, further delays in approving the Dissolution Proposal will result in continued operating costs and expenses - reducing or eliminating funds available for distribution to stockholders. Approving the Dissolution Proposal will allow Vincerx to move forward expeditiously and maximize the likelihood and amount of distributions to stockholders. - Recognize Potential Tax Benefits. U.S. stockholders who receive less than their tax basis in their shares could be eligible to recognize a capital loss for U.S. federal income tax purposes. Timely approval of the Dissolution Proposal will facilitate this recognition.
Every vote matters. Stockholders must ACTIVELY VOTE for their vote to count. Any delay in approving the Dissolution Proposal will result in increased expenditures and reduce the likelihood and amounts available for distribution to stockholders.
Voting is quick and simple:
- BY PHONE: Please call Advantage Proxy, Vincerx’s proxy solicitor, toll-free at 1-877-870-8565 between the hours of 9:00 a.m. and 9:00 p.m., Eastern Time, Monday through Friday. You can also contact Advantage Proxy if you have any questions about voting.
- BY INTERNET: Vote by going to www.proxyvote.com and entering the control number on your proxy card or by following the instructions provided by your broker, bank, or other nominee.
Your vote FOR the Dissolution Proposal is very important - please VOTE TODAY.
Additional Information
Information regarding the Dissolution Proposal, including the board of director’s reasons for recommending approval of the Dissolution Proposal, is set forth in the company’s proxy statement and supplements thereto, which have been filed with the Securities and Exchange Commission (“SEC”) and are available at the SEC’s website at www.sec.gov.
Forward-Looking Information
This press release contains forward-looking statements within the meaning of the federal securities laws including, but not limited to, statements about the reasons for approving, and the consequences of failing to approve, the Dissolution Proposal; the amounts potentially available for distribution to stockholders; and the potential tax benefits to stockholders of approving the Dissolution Proposal. Forward-looking statements involve risks and uncertainties that may cause actual results or performance to differ materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, risks involved in dissolving, liquidating, and winding down Vincerx’s business and affairs; the timing and amount of distributions, if any, to Vincerx’s stockholders, and the accuracy of, and changes to, the assumptions used in estimating such amounts; Vincerx’s operating costs and expenses, including any unexpected costs, expenses, or claims; the ability to obtain stockholder approval of the Dissolution Proposal and the timeliness of such approval; the risk that Vincerx may need to seek alternatives to the Dissolution, including seeking protection of the bankruptcy court; and the other factors discussed in Vincerx’s SEC reports, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, and subsequent reports filed with the SEC. All forward-looking statements are based on information available to Vincerx as of the date of this press release. Vincerx undertakes no duty or obligation to update these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Contact Information:
info@vincerx.com
FAQ
What is the estimated distribution range for VINC stockholders after dissolution?
When is Vincerx Pharma's Special Meeting of Stockholders scheduled for 2025?
What happens if VINC stockholders don't approve the dissolution proposal?
How can VINC stockholders vote on the dissolution proposal?
What are the potential tax implications for VINC stockholders from the dissolution?
